JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M413377200 on December 20, 2004

J. Biol. Chem., Vol. 280, Issue 9, 7654-7658, March 4, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/9/7654    most recent
M413377200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Welcker, M.
Right arrow Articles by Clurman, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Welcker, M.
Right arrow Articles by Clurman, B. E.
Related Collections
Right arrow Papers Of The Week
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The SV40 Large T Antigen Contains a Decoy Phosphodegron That Mediates Its Interactions with Fbw7/hCdc4*{diamondsuit}

Markus Welcker{ddagger} and Bruce E. Clurman{ddagger}§¶||

From the Divisions of {ddagger}Human Biology and §Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109 and the Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98104

Cell transformation by simian virus 40 (SV40) results mostly from the highly oncogenic activities of the large T antigen (LT), which corrupts the cellular checkpoint mechanisms that guard cell division and the transcription, replication, and repair of DNA. The most prominent LT targets are the retinoblastoma protein (pRb) and p53. Here we report that LT binds directly to Fbw7, the substrate recognition component of the SCFFbw7 ubiquitin ligase and a human tumor suppressor. LT binding mislocalizes the nucleolar Fbw7{gamma} isoform to the nucleoplasm. Interestingly, the binding of LT to Fbw7 occurs via a decoy phospho-epitope within the C terminus of LT that closely mimics the consensus Cdc4 phospho-degron found within Fbw7 substrates. We demonstrate that, using this mode of interaction, LT can interfere with Fbw7-driven cyclin E turnover in vivo and causes increased cyclin E-associated kinase activity. Our data suggest that LT competes with cellular proteins for Fbw7 binding in a substrate-like fashion.


Received for publication, November 29, 2004

* This work was supported by NCI (National Institutes of Health) Grants RO1CA84069 and RO1CA102742 (to B. E. C.) and by the Leukemia and Lymphoma Society (to M. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{diamondsuit} This article was selected as a Paper of the Week.

|| A W. M. Keck Distinguished Young Investigator in Medical Research. To whom correspondence should be addressed: Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, Seattle, WA 98109. Tel.: 206-667-4524; Fax: 206-667-5255; E-mail: bclurman{at}fhcrc.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
B. G. Bajaj, M. Murakami, Q. Cai, S. C. Verma, K. Lan, and E. S. Robertson
Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein
J. Virol., April 15, 2008; 82(8): 4082 - 4090.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. J. Thompson, S. Buonamici, M. L. Sulis, T. Palomero, T. Vilimas, G. Basso, A. Ferrando, and I. Aifantis
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
J. Exp. Med., August 6, 2007; 204(8): 1825 - 1835.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. Barry and K. Fruh
Viral Modulators of Cullin RING Ubiquitin Ligases: Culling the Host Defense
Sci. Signal., May 16, 2006; 2006(335): pe21 - pe21.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. C. Y. Lee, A. Frolov, R. Li, G. Ayala, and N. M. Greenberg
Targeting aurora kinases for the treatment of prostate cancer.
Cancer Res., May 15, 2006; 66(10): 4996 - 5002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.